tert-Butyl (3-hydroxyphenyl)(methyl)carbamate, 95%, 250mg

5-Bromo-2,4-dichloro-6-(trifluoromethyl)pyrimidine, 95.0%, 5g

1-((2R,4S,5R)-4-((TRIETHYLSILYL)OXY)-5-(((TRIETHYLSILYL)OXY)METHYL)TETRAHYDROFURAN-2-YL)-5-VINYLPYRIMIDINE-2,4(1H,3H)-DIONE, 95%, 100mg

8-FLUOROQUINOLINE-4-CARBOXYLIC ACID, 95.0%, 5g

5-(tert-Butyl) 2-ethyl 7,8-dihydro-4H-pyrazolo[1,5-a][1,4]diazepine-2,5(6H)-dicarboxylate, 95%, 1g

1-(2-Oxopropyl)-5-(trifluoromethyl)-1,2-dihydropyridin-2-one, 95%, 250mg

4,7-Dimethoxy-1H-indole-2-carboxylic acid methyl ester, 95.0%, 5g

(3-Fluorooxetan-3-yl)methyl 4-methylbenzenesulfonate, 95.0%, 1g

Matraces de fondo redondo de tres bocas con cuellos laterales paralelos, 6000 ml, 29/32, 14/23, 1 unidad

3,5-Difluoro-N,N-dimethylaniline, 98.0%, 1g

Éster etílico de ácido fórmico, mínimo 99 %, 1 l, envase de vidrio

1-(2,5-Dioxoimidazolidin-4-yl)urea, 98.0%, 100g

3-Fluoro-5-methoxyaniline, 95.0%, 25g